Sedative Abuse Completed Phase 1 Trials for Pentobarbital (DB00312)

IndicationStatusPhase
DBCOND0030325 (Sedative Abuse)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00058955Physiological, Behavioral and Subjective Effects of Drugs (GHB)Prevention